Chinese Markets for Bladder Cancer Treatment Drugs

Chinese Markets for Bladder Cancer Treatment Drugs

China's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

TABLE OF CONTENTS



I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook

Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade

Financial and Tax Regulations

Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Bladder Cancer Treatment Drugs Industry Structure
Market Size
Market Growth Drivers
Bladder Cancer Treatment Drugs Sales Volume
Major Producer Facility Locations
Major Producers’ Sales Volume and Market Share
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Bladder Cancer Overview
Bladder Cancer Treatment Drugs Market Overview
Bladder Cancer Treatment Drugs Market Overview by Classification
Intraluminal Perfusion Agents
Unilateral Chemotherapy Drug
First-line Chemotherapy Drug
Immunomodulator
Other Drugs
Bladder Cancer Treatment Drugs Import and Export by Classification
Bladder Cancer Treatment Drugs Import
Bladder Cancer Treatment Drugs Export
Market Overview by Drug’s Active Principle
Market Overview by Producers
Pricing Trend

V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK

Bladder Cancer Treatment Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKETING STRATEGIES

China Market Entry Overview
China’s Distribution System
Bladder Cancer Treatment Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications

China’s Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

VII. BLADDER CANCER TREATMENT DRUGS PRODUCER DIRECTORY

Profiles of Bladder Cancer Treatment Drugs Producers























LIST OF TABLES



I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Top 14 Bladder Cancer Treatment Drugs Sales Volume and Market Share in 2008
Bladder Cancer Treatment Drugs Sales Volume
Major Producer Facility Location
Major Bladder Cancer Treatment Drugs Producer Sales Volume and Their Market Share in 2008
Major Foreign Investment in China

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Bladder Cancer Treatment Drugs Import by Country in 2008
Bladder Cancer Treatment Drugs Export by Country in 2008
Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification
Bladder Cancer Treatment Drugs Import by Drugs Classification
Bladder Cancer Treatment Drugs Export by Drugs Classification
Top 14 Bladder Cancer Treatment Drugs Medication Value and Their Market Share in 2008
Top 14 Bladder Cancer Treatment Drugs Sales Volume and Their Market Share in 2008
Bladder Cancer Treatment Drugs Major Producer, Sales Volume, and Market Share in 2008


V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK

Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits



























LIST OF CHARTS



I. INTRODUCTION

Bladder Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Bladder Cancer Treatment Drugs Sales Volume
Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification in 2008
Top 14 Bladder Cancer Treatment Drugs Market Share in 2008

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Bladder Cancer Treatment Drugs Sales Volume
Bladder Cancer Treatment Drugs Import
Bladder Cancer Treatment Drugs Import by Country in 2008
Bladder Cancer Treatment Drugs Export
Bladder Cancer Treatment Drugs Export by Country in 2008
Bladder Cancer Treatment Drugs Sales Volume by Classification in 2008
Intraluminal Perfusion Agents Sales Volume and Market Share
Unilateral Chemotherapy Drug Sales Volume and Market Share
First-Line Chemotherapy Drug Sales Volume and Market Share
Immunomodulator Sales Volume and Market Share
Other Drugs Sales Volume and Market Share
Bladder Cancer Treatment Drugs Import by Classification in 2008
Unilateral Chemotherapy Drug Import and Market Share
First-Line Chemotherapy Drug Import and Market Share
Intraluminal Perfusion Agents Import and Market Share
Immunomodulator Import and Market Share
Other Drugs Import and Market Share
Bladder Cancer Treatment Drugs Export by Drugs Classification in 2008
Unilateral Chemotherapy Drug Export and Market Share
First-Line Chemotherapy Drug Export and Market Share
Intraluminal Perfusion Agents Export and Market Share
Immunomodulator Export and Market Share

VI. MARKETING STRATEGIES

China’s Distribution Channel